Literature DB >> 23129341

Nichotherapy for stem cells: there goes the neighborhood.

Jean-Pierre Levesque1, Ingrid G Winkler, John E J Rasko.   

Abstract

Stem cells and their malignant counterparts require the support of a specific microenvironment or "niche". While various anti-cancer therapies have been broadly successful, there are growing opportunities to target the environment in which these cells reside to further improve therapeutic efficacy and outcome. This is particularly true when the aim is to target normal or malignant stem cells. The field aiming to target or use the niches that harbor, protect, and support stem cells could be designated as "nichotherapy". In this essay, we provide a few examples of nichotherapies. Some have been employed for decades, such as hematopoietic stem cell mobilization, whereas others are emerging, such as chemosensitization of leukemia stem cells by targeting their niche.
Copyright © 2013 WILEY Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23129341     DOI: 10.1002/bies.201200111

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  6 in total

1.  It takes nerves to recover from chemotherapy.

Authors:  Jean-Pierre Levesque; Ingrid G Winkler
Journal:  Nat Med       Date:  2013-06       Impact factor: 53.440

Review 2.  Metabostemness: a new cancer hallmark.

Authors:  Javier A Menendez; Tomás Alarcón
Journal:  Front Oncol       Date:  2014-09-29       Impact factor: 6.244

3.  The nutritional phenome of EMT-induced cancer stem-like cells.

Authors:  Elisabet Cuyàs; Bruna Corominas-Faja; Javier A Menendez
Journal:  Oncotarget       Date:  2014-06-30

4.  Perspective: Biophysical regulation of cancerous and normal blood cell lineages in hematopoietic malignancies.

Authors:  Sing Wan Wong; Stephen Lenzini; Jae-Won Shin
Journal:  APL Bioeng       Date:  2018-05-22

5.  Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance.

Authors:  Valerie Barbier; Johanna Erbani; Corrine Fiveash; Julie M Davies; Joshua Tay; Michael R Tallack; Jessica Lowe; John L Magnani; Diwakar R Pattabiraman; Andrew C Perkins; Jessica Lisle; John E J Rasko; Jean-Pierre Levesque; Ingrid G Winkler
Journal:  Nat Commun       Date:  2020-04-27       Impact factor: 14.919

6.  Dynamic Cross Talk between S1P and CXCL12 Regulates Hematopoietic Stem Cells Migration, Development and Bone Remodeling.

Authors:  Karin Golan; Orit Kollet; Tsvee Lapidot
Journal:  Pharmaceuticals (Basel)       Date:  2013-09-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.